跳至主要内容
临床试验/NCT04521959
NCT04521959已完成不适用

The Effect Of Blood Flow Restrıcted Resistive And Aerobic Exercises in Chronic Obstructive Pulmonary Patients

Medipol University2 个研究点 分布在 2 个国家目标入组 40 人开始时间: 2020年8月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
FEV1/FVC rate

研究概览

简要总结

Patients with chronic obstructive pulmonary disease (COPD) classified by a pulmonologist in accordance with the GOLD criteria will be randomly divided into 2 groups.

The first group (n = 20) was accompanied by blood flow restriction (CAC), 3 times a week, 8 weeks, 1RMx 30% intensity, 10 repetitions, 3 sets, 30 seconds rest interval, progressive resistance exercise (PRE) and after 5 minutes of rest by cycling. Progressive aerobic exercise (AE) (BFR PRE + AE group) in the target heart rate range of 50-80% intensity will be applied to the second group (n = 20), PRE and AE (PRE + AE group) performed at the same intensity and duration without BFR.

详细描述

Determination of application groups: Patients with chronic obstructive pulmonary disease (COPD) classified by a pulmonologist in accordance with the GOLD criteria will be randomly divided into 2 groups and application groups will be determined.

Applications to be made:

The first group (n = 20) accompanied by BFR; Progressive resistance training (RT) 3 times a week, 1RMx 30% intensity, 10 repetitions, 3 sets, 30 seconds rest interval, and cycling after 5 minutes rest, progressive aerobic training (AT)in the target heart rate range of 40-80% intensity will be applied.

To the second group (n = 20) without BFR; 3 times a week, 8 weeks, 1RMx 30% intensity, 10 repetitions, 3 sets, 30 seconds of rest interval, and after 5 minutes of rest will be applied in the target heart rate range of 40-80%, which is done by cycling.

Calculation of 1RM: Epley formula will be used in the calculation. According to this; 1 RM = (1 + .0333 x number of repetitions) x weight removed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

40 COPD patients will be randomised divided into two equal groups according to age, gender and disease severity.

入排标准

年龄范围
40 Years 至 78 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Being diagnosed with mild to severe COPD according to GOLD criteria in the age range of 40-78
  • No drug change for at least 30 days
  • Not participating in a structured activity program for at least six months
  • Have the ability to cooperate.

排除标准

  • Presence of any pathology that limits physical activity performance
  • Presence of severe or unstable heart disease
  • Presence of peripheral artery disease
  • Being in an exacerbation period of the disease
  • Presence of another active disease (rheumatic, oncological, traumatic etc.)
  • Any neurological or orthopedic disease that prevents exercise

研究组 & 干预措施

Blood Flow Restricted Aerobic and Resistance Exercise Group

Active Comparator

kan akımı kısıtlanarak.direnç ve bisikletle aerobik egzersiz uygulanacak

干预措施: Blood flow restricted and normal aerobic exercise and resistance exercise (Procedure)

Normal aerobik ve direnç egzersiz grubu

Active Comparator

Normal şartlarda aerobik ve direnç egzersizi uygulanacak

干预措施: Blood flow restricted and normal aerobic exercise and resistance exercise (Procedure)

结局指标

主要结局

FEV1/FVC rate

时间窗: eight weeks

respiratory function test

total antioxidant status

时间窗: eight weeks

oxidative stress marker

oxygen saturation

时间窗: three times a week

blood gas test

six minute walk test

时间窗: eight weeks

strength evaluation

c reactive protein

时间窗: eight weeks

thrombus formation risk marker

heart rate

时间窗: three times a week

for exercise dose determination

ST george's respiratory questionnaire

时间窗: eight weeks

used to evaluate the effects of respiratory disease's symptoms and illness

quadriceps muscle diameter

时间窗: eight weeks

Measurement of change in muscle volume

creatine kinase

时间窗: eight weeks

muscle breakdown marker

d-dimer

时间窗: eight weeks

venous thromboembolism marker

total oxidant status

时间窗: eight weeks

oxidative stress marker

interleukin 6

时间窗: eight weeks

inflammation marker

次要结局

未报告次要终点

研究者

发起方
Medipol University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmet Gunes

PhD Student

Medipol University

研究点 (2)

Loading locations...

相似试验